All products / DC28353
Etilevodopa
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100mg | $850 USDRequest a quote → |
| 250mg | $1,500 USDRequest a quote → |
| 1g | $3,000 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
Etilevodopa (L-Dopa ethyl ester), an ethyl-ester prodrug of Levodopa, is rapidly hydrolyzed to Levodopa and ethanol by nonspecific esterases in the gastrointestinal tract. Etilevodopa is used for the treatment of Parkinson disease (PD). Levodopa is the direct precursor of dopamine and is a suitable prodrug as it facilitates CNS penetration and delivers dopamine[1][2][3].
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC28353 |
|---|---|
| Product name | Etilevodopa |
| CAS | 37178-37-3 |
| Molecular formula | C11H15NO4 |
| Molecular weight | 225.241103410721 |
| Purity | >98% |
| SMILES | CCOC([C@H](CC1C=CC(O)=C(O)C=1)N)=O |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — Etilevodopa (DC28353)Source references
[1]. Djaldetti R, et al. Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized, crossover study. Clin Neuropharmacol. 2003 Nov-Dec;26(6):322-6. [2]. Blindauer K, et al. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. Arch Neurol. 2006 Feb;63(2):210-6. [3]. Haddad F, et al. Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease. Molecules. 2017 Dec 25;23(1). pii: E40.
